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Abstract
Background: Fibromyalgia (FM) is characterised by diffuse musculoskeletal pain and stiffness at
multiple sites, tender points in characteristic locations, and the frequent presence of symptoms
such as fatigue. The aim of this study was to assess whether the myoelectrical manifestations of
fatigue in patients affected by FM are central or peripheral in origin.
Methods: Eight female patients aged 55.6 ± 13.6 years (FM group) and eight healthy female
volunteers aged 50.3 ± 9.3 years (MCG) were studied by means of non-invasive surface
electromyography (s-EMG) involving a linear array of 16 electrodes placed on the skin overlying
the biceps brachii muscle, with muscle fatigue being evoked by means of voluntary and involuntary
(electrically elicited) contractions. Maximal voluntary contractions (MVCs), motor unit action
potential conduction velocity distributions (mean ± SD and skewness), and the mean power
frequency of the spectrum (MNF) were estimated in order to assess whether there were any
significant differences between the two groups and contraction types.
Results: The motor pattern of recruitment during voluntary contractions was altered in the FM
patients, who also showed fewer myoelectrical manifestations of fatigue (normalised conduction
velocity rate of changes: -0.074 ± 0.052%/s in FM vs -0.196 ± 0.133%/s in MCG; normalised MNF
rate of changes: -0.29 ± 0.16%/s in FM vs -0.66 ± 0.34%/s in MCG). Mean conduction velocity
distribution and skewnesses values were higher (p < 0.01) in the FM group. There were no
between-group differences in the results obtained from the electrically elicited contractions.
Conclusion: The apparent paradox of fewer myoelectrical manifestations of fatigue in FM is the
electrophysiological expression of muscle remodelling in terms of the prevalence of slow
conducting fatigue-resistant type I fibres. As the only between-group differences concerned
voluntary contractions, they are probably more related to central motor control failure than
muscle membrane alterations, which suggests pathological muscle fibre remodelling related to
altered suprasegmental control.
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FM is characterised by diffuse musculoskeletal pain and
stiffness at multiple sites, tender points at characteristic
locations, and the frequent presence of symptoms such as
fatigue, poor sleep, irritable bowel symptoms and chronic
headache [1,2].
Various theories have been put forward to explain such a
wide range of symptoms, including altered nociceptive
afferent input from muscles with the sensitisation of pri-
mary afferent pathways [3], systemic failure of the sensory
integration of nociceptive inputs and anti-nociceptive
responses [4,5], primitive sleep-related electroencephalo-
gram (EEG) alterations [6], and alterations in the neu-
roendocrine and immune systems [7]. A review of the
various theories has recently been published [8]. Studies
of the main features of FM (muscle pain and fatigue) have
failed to produce unequivocal results in terms of func-
tional muscle changes as a possible pathological basis for
the presence of muscle pain, and the results of biopsy
studies do not support any clear-cut conclusions as some
[9,10] have failed to find any definite evidence of muscle
disease, and others have only found non-specific
myopathological patterns [11]. Furthermore, the tradi-
tional invasive approach is not well tolerated, cannot be
frequently repeated, and small bioptic specimens can only
provide a limited description of the sampled muscle. It
also leaves a number of open questions concerning the
reproducibility of the results and the possibility of infer-
ring the changes induced by treatments.
Multichannel surface electromyography (s-EMG) signal
acquisition and processing can extract information from
the signal redundancy provided by the multichannel
recording [12-14] that correlates with acute alterations in
motor unit recruitment strategies [15] and/or chronic
modifications in the type, distribution, number or size of
muscle fibres [16], and is reflected by alterations in
mechanical and/or s-EMG manifestations of fatigue.
Although some previously published studies have related
FM and s-EMG [17,18], they provide no information con-
cerning changes in the myoelectrical manifestations of
fatigue as a marker of muscle functional reorganisation in
FM. The aims of this non-invasive EMG-based (s-EMG)
study of fibromyalgic patients and a matched control
group were to assess whether FM muscle is different in
terms of the development of muscle fatigue (i.e. whether
there are any differences in the variables estimated from s-
EMG signals), and whether these differences (if any) are
associated with pathological alteration in central sensory-
motor control strategies or peripheral changes in the neu-
romuscular system.
Methods
Subjects
The study involved 16 women: eight had been diagnosed
as having fibromyalgia on the basis of the American Col-
lege of Rheumatology (ACR) criteria [1] (the FM group);
the other eight were healthy sedentary controls matched
for age, gender and physical activity [19] (MCG). Pain was
assessed using the McGill Pain Questionnaire Short Form
(MPQ-SF) [20] and the severity of FM symptoms by
means of the FibroFatigue Scale (FFS) [21]. (Table 1).
The possible non-homogeneity of the FM population has
been reported since the early nineties [22,23], but the sub-
group distribution of the whole FM population has not
yet been fully studied. Possible differentiations have been
related to the onset of the disease: reactive traumatic (both
physical and emotional) or primitive, but there are no
substantial clinical differences between the two groups
[24]. This has also been also confirmed by more recent
data from Riberto et al. [25]. For these reasons the sample
was considered clinically homogeneous and subjects were
only excluded if they were simultaneously affected by any
other rheumatological disease or high blood pressure (or
receiving anti-hypertensive treatment such as clonidine);
any infectious or viral diseases during the previous three
Table 1: Subject characteristics
MCG FM p level
Age (years) 50.3 ± 9.3. 55.6 ± 13.6 NS
Body Mass (kg) 59.4 ± 18.3 56.25 ± 16 NS
Height (cm) 162.5 ± 10.3 159.3 ± 6.5 NS
Physical activity [18] 4.9 ± 1.9 3.3 ± 1.5 NS
Symptoms duration (years) 9.3 ± 1.3
MPQ-SF [19]
Intensity (0–45) 26.1 ± 9.9
Total words (0–15) 11.1 ± 4.3
Present Pain Intensity (0–5 pts scale) 3.4 ± 0.5
FFS [20]
Total score 39.1 ± 2.4
Values are expressed as Mean ± SD.
FM = Fibromyalgic Patients; MCG = Matched Control Group; MPQ-SF = McGill Pain Questionnaire Short Form; FFS = Fibro Fatigue Score; NS = 
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diseases or any other neurological or psychiatric disorder
that may have hindered them from doing the required
task; or if they were regularly receiving antidepressants,
opiates or anti-epileptic drugs. All of the enrolled subjects
underwent 48 hours' washout of analgesic drugs.
Although paracetamol was allowed as a rescue drug, none
of the subjects were under the influence of any drug dur-
ing the s-EMG recording session.
The thickness of the subcutaneous tissue under the elec-
trodes was estimated using a skin fold caliper (Gima, Ges-
sate, Milan, Italy) in order to eliminate the volume
conductor between the signal source (the muscle) and the
recording device (the electrodes) as a confounding factor
between the groups [26].
The study was approved by the "Foundation Salvatore
Maugeri", Pavia Italy, Ethics Committee, and was con-
ducted in accordance with the principles of the Declara-
tion of Helsinki; all of the subjects gave their informed
consent.
Instrumental measurements
The myoelectrical signals were detected from the biceps
brachii muscle of the dominant side, which was selected
because: 1) it is a muscle, and not a site of any of the 18
myalgic points used to classify FM, and was not a site of
spontaneous pain in our patients, and so the presence of
incident pain could not be considered the local cause of
an altered muscle contraction; 2) it is easily accessible for
electrode placement; 3) it does not cause patient discom-
fort; 4) it allows the recording of high quality signals; and
5) published normative data are available [27].
After being picked up by a linear array of 16 electrodes (1
mm diameter silver contacts positioned 10 mm apart) in
single differential configuration [28], the myoelectrical
signals were passed through a 10–450 Hz bandwidth fil-
ter, amplified (EMG16-16 channel amplifier, LISiN Bio-
engineering Centre, Turin Polytechnic, Italy), sampled at
2048 Hz, digitised by a 12-bit A/D converter (DAQCARD-
6024E National Instruments, Austin, Texas, USA), and
stored on a personal computer.
Experimental protocol
Each subject lay supine on a bed with the dominant arm
horizontal and abducted to 90°. The forearm was 120°
flexed (180° being full extension), with the hand supi-
nated. The arm was placed in an isometric brace (MISO1,
LISiN Bioengineering Centre, Turin Polytechnic, Italy),
which was equipped with two torque transducers (one on
each side of the arm) and connected to a display that pro-
vided the subject with visual feedback of the torque level
produced (Figure 1).
The subjects were asked to perform a brief (3–5 second)
isometric flexion contraction that allowed the quality of
the myoelectrical signals to match the criteria described in
detail by Rainoldi et al. [29], and then performed three 3-
second maximum voluntary contractions (MVCs) under
isometric conditions, separated by 5-minute intervals. The
contraction showing the highest force value was selected
as the reference MVC, thus allowing sub-maximal targets
to be set on the visual feedback display.
After the MVC had been assessed, the motor points of the
biceps brachii were identified and marked on the skin,
and the one with the greatest mechanical response and
lowest current intensity was chosen for the electrically
elicited contraction session.
After placing an adhesive stimulation electrode (area = 9
cm2, Spes Medica, Vignate, Milan, Italy) on the selected
motor point, a rectangular current pulse was applied using
a time width of 0.3 ms and a frequency of 25 Hz; the stim-
ulation was supramaximal (about 10% above the level
generating the peak M-wave or the maximum level toler-
ated by the subjects). Two electrically elicited 30-second
contractions separated by a 10-minute rest were per-
formed at each experimental session. The 25 Hz stimula-
tion was judged not to be unbearable or uncomfortable by
all of the subjects in both groups.
After a further five minutes' rest, the subjects were asked to
perform two voluntary contractions at 30% MVC and two
at 60% MVC in a randomised sequence; the contractions
lasted 30 seconds and were separated by 5-minute rest
periods. This procedure is usually adopted in our lab to
allow subjects to familiarise themselves with the protocol
without inducing fatigue or a learning effect; only the data
relating to the second contractionswere recorded and ana-
lysed.
Data analysis
The initial values and rates of change in mean spectral fre-
quency (MNF), average rectified value (ARV) and conduc-
tion velocity (CV) were computed off-line by means of
numerical algorithms [30] using non-overlapping signal
epochs of 0.5 seconds, thus generating 60 estimates of
each variable during the 30-second contractions.
The correlation coefficient (CC) between the two adjacent
double differential (DD) signals was used to ensure cor-
rect electrode positioning and the reliability of the CV esti-
mates.
Linear regression analysis was used to calculate the initial
values and rates of change in MNF, ARV and CV during the
voluntary and electrically elicited contractions. The nor-
malised rate of change (the ratio between the rate ofPage 3 of 9
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variables. As demonstrated elsewhere [27], this normali-
sation highlights differences in the myoelectrical manifes-
tations of fatigue that may be related to different pools of
activated motor units.
Motor unit action potentials (MUAPs) were extracted
from the 13 DD channels only during the voluntary con-
traction [13]. For each identified MUAP, the muscle fibre
CV was estimated from the surface EMG signal using 3–7
adjacent DD channels in order to obtain a CC of > 0.75
and a CV > 8 m/s [31]. The selected channels included
those used to estimate the global EMG variables.
The MUAP CV distributions were calculated for each con-
traction using epochs of one second. In this way, the ini-
tial values and rates of change were obtained by pooling
the behaviour of each MU, and not by using the whole sig-
nal providing the "global" variables.
In order to compare general behaviour in the MCG and
FM group, the data were pooled at each contraction level.
The non-parametric Mann-Whitney U test for independ-
ent samples was used to identify any significant between-
group differences in the s-EMG variables, and the non-
parametric Kolmogorov-Smirnov test was used to com-
pare CV distributions. A p value of < 0.05 was considered
statistically significant.
Results
None of the subjects reported any localised biceps brachii
muscle pain during the MVCs or any worsening in FM
pain interfering with their ability to perform the requested
task, possibly because of the brevity of the required mus-
cle contraction (3 sec).
Table 2 shows the estimates of the EMG variables during
the electrically elicited contractions. There were no
between-group differences in the initial values or rates of
change. The 25 Hz stimulation was judged to be not
unbearable or uncomfortable by all of the subjects in both
groups.
There were no statistically significant differences in the
voluntary contractions at 30% MVC.
Table 3 shows the s-EMG variables during voluntary con-
tractions at 60% of MVC and maximal MVC. The MVCs in
the two groups were not statistically different. There were
no between-group differences in the initial values and
rates of change of the EMG variables, except for the MNF
rate of change and the normalized rate of change at 60%
MVC, which were higher in the MCG, thus indicating
greater myoelectrical fatigue.
The CV rate of change and the normalised rate of change
calculated from the extracted MUAP pool at 60% MVC
were both higher in the MCG (-0.009 ± 0.007 vs -0.004 ±
0.003 m/s2, p = 0.031; and -0.196 ± 0.133%/s vs -0.074 ±
0.052%/s, p = 0.015), and in line with those obtained
from the global MNF estimates.
CV distributions were statistically broader in the FM group
at the beginning and end of the 60% MVC (p < 0.001, Kol-
mogorov-Smirnov test, Figure 2).
The CV distribution symmetry index (skewness) of the
two groups was higher in the FM group at 60% MVC (1.77
The experimental set upFigure 1
The experimental set up. The subject lies supine on a bed with the dominant arm horizontal and abducted to 90°. The 
forearm is 120° flexed (180° being full extension), with the hand supinated. The arm is placed in an isometric brace equipped 
with two torque transducers (one on each side of the arm) connected to a display that provides the subject with visual feed-
back of the torque level produced. The myoelectrical signals are picked up by a linear array of 16 electrodes placed on the skin 
overlying the biceps brachii muscle. The linear array can be identified as a white band on the biceps brachii.Page 4 of 9
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Positive values correspond to a deviation from the normal
bell-shaped curve, and show that the CV distribution
curves in the symptomatic group were steeper on the left
because of the contribution of higher CV values. This
behaviour was more pronounced at the beginning of the
contraction.
The absence of any significant between-group difference
in subcutaneous tissue thickness means that this did not
have a confounding effect on the MNF or CV estimates
[26].
Discussion
The correlation between muscle pain and the sensation of
fatigue in FM is considered a generalised muscle response
[32], and has been studied using traditional EMG needle
electrodes [18] and the surface montages mainly used for
s-EMG biofeedback [32]. The latter have also been used
for therapeutical interventions although, as stated in a
recent overview of rehabilitation interventions in FM [33],
their efficacy is still unproven. However, neither tech-
nique has detected any alterations in the muscle contrac-
tions of FM patients. Furthermore, they cannot be used to
investigate the rate of the development of fatigue in differ-
ent muscle fibres or possible differences in the fibre con-
stitution of normal and FM muscles as they do not
provide clear-cut data concerning primary muscle involve-
ment in the abnormal perception of fatigue characteristic
of FM.
The perception of fatigue and its mechanical conse-
quences (the impossibility of maintaining a given motor
task) are the final expression of a series of electrochemical
events that start within the neuromuscular system and go
from the beginning of the motor command to the end of
the muscle contraction, and its has been clearly docu-
mented that FM patients complain about fatigue and mis-
judge their physical activity [32,34]. This biases almost all
of the studies based on prolonged, strenuous or sustained
periods of muscle contraction or the use of needle elec-
trode because FM patient have very low pain thresholds,
Table 2: The results of the non-parametric Mann-Whitney U test
MCG FM p level
CV initial values (m/s) 4.07 ± 0.45 4.32 ± 0.36 NS
CV rate of change (m/s2) -0.02 ± 0.01 -0.02 ± 0.01 NS
CV norm. rate of change (%/s) -0.50 ± 0.29 -0.46 ± 0.23 NS
MNF initial values (Hz) 62.28 ± 17.22 57.63 ± 13.26 NS
MNF rate of change (Hz/s) -0.43 ± 0.29 -0.44 ± 0.19 NS
MNF norm. rate of change (%/s) -0.64 ± 0.31 -0.74 ± 0.20 NS
ARV initial values (mV) 28.53 ± 13.12 21.24 ± 9.44 NS
ARV rate of change (mV/s) 0.17 ± 0.22 0.16 ± 0.15 NS
ARV norm. rate of change (%/s) 0.58 ± 0.72 0.78 ± 0.64 NS
Mean values ( ± SD) of EMG variables during electrically elicited contractions in the two groups. The results of the non parametric Mann-Whitney 
U test are reported.
MCG = Matched Control Group, FM = Fibromyalgic group, MVC = maximal voluntary contraction, CV = conduction velocity, MNF = mean 
spectral frequency, ARV = average rectified value; NS = non significative
Table 3: Mean values ( ± SD) of mechanical and EMG variables during voluntary contractions at 60%
MCG FM p level
MVC (Nm) 18.16 ± 7.89 14.97 ± 6.73 NS
CV initial values (m/s) 4.37 ± 0.34 4.58 ± 0.49 NS
CV rate of change (m/s2) -0.01 ± 0.01 -0.01 ± 0.01 NS
CV norm. rate of change (%/s) -0.25 ± 0.33 -0.19 ± 0.19 NS
MNF initial values (Hz) 93.00 ± 14.58 87.21 ± 25.35 NS
MNF rate of change (Hz/s) -0.59 ± 0.29 -0.25 ± 0.14 0.036
MNF norm. rate of change (%/s) -0.66 ± 0.34 -0.29 ± 0.16 0.046
ARV initial values (mV) 93.40 ± 46.03 77.84 ± 54.02 NS
ARV rate of change (mV/s) 1.29 ± 1.47 0.68 ± 0.66 NS
ARV norm. rate of change (%/s) 1.23 ± 1.24 0.74 ± 0.41 NS
Mean values ( ± SD) of mechanical and EMG variables during voluntary contractions at 60% MVC in the two groups. The results of the non 
parametric Mann-Whitney U test (in bold those significant) are reported.
MCG = Matched Control Group, FM = Fibromyalgic Group, MVC = maximal voluntary contraction, CV = conduction velocity, MNF = mean 
spectral frequency, ARV = average rectified value; NS = non significativePage 5 of 9
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:78 http://www.biomedcentral.com/1471-2474/10/78but can be avoided by analysing s-EMG recordings of
short (3-second) muscle contraction periods which, at
least in our experience, do not give rise to any idiosyncra-
sies or kinesiophobic behaviour.
Changes in s-EMG signals over time reflect the early phys-
iological phenomena evolving during sustained muscle
contraction, and account for the so-called "myoelectrical
manifestations of fatigue", which are affected by (and
therefore reflect) the constitution of muscle fibres. One
way of distinguishing the two main types of motor unit
(MU) is by means of their susceptibility to electrical
fatigue, and their mechanical response to it: fast (type II)
MUs produce force twitches characterised by a short time
to peak and rapid fatigue, whereas slow (type I) MUs take
longer to peak and ans are slower to tire. The former usu-
ally have larger fibres and higher CV values than the latter
[12]. In other words, a muscle with more type I fibres
develops less myoelectrical fatigue, whereas one charac-
terised by a high percentage of type II fibres is more pow-
erful but less resistant to fatigue.
The strategy of activating these two main types of MU dur-
ing a voluntary contraction is based on Henneman's "size
principle", which states that progressively larger MUs
characterised by larger CVs are recruited with increasing
CV distributions in the FM and MCG groups: beginning and ending at 60% MVCFigure 2
CV distributions in the FM and MCG groups: beginning and ending at 60% MVC. CV distributions in the FM (top) 
and MCG group (bottom) shown as two-second epochs at the beginning and end of a 60% MVC. Mean CV distribution values 
and skewnesses were significantly higher in the FM group (p < 0.001, Kolmogorov-Smirnov test). The numbers of identified 
MUAPs are also shown. MCG = matched control group; FM = fibromyalgia; s-EMG = surface electromyography; MVC = maxi-
mal voluntary contraction; MNF = mean power frequency of the spectrum; CV = conduction velocity; MPQ-SF = McGill Pain 
Questionnaire Short Form; FFS = Fibrofatigue Scale; ARV = average rectified value; CC = correlation coefficient; MUAP = 
motor unit action potential; MU = motor unit; DD = double differential.
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activate the whole MU pool (mainly type I fibres),
whereas an MVC of 60% or more does (type I and II
fibres) [36-38].
The absence of significant differences between the two
groups in the s-EMG parameters observed during 30%
MVC contractions was due to the partial activation of the
MU pool induced at submaximal contraction level. This is
in line with the significant findings observed at 60% MVC:
i.e. a contraction level at which the whole biceps brachii
MU pool is recruited.
MU recruitment can be modified by diseases, aging and/
or processes of adaptation: for example, the physiological
reduction in the number and size of type II fibers in the
elderly leads to paradoxically fewer myoelectrical mani-
festations of fatigue than in younger subjects [39].
On the basis of these premises, each set of data will be dis-
cussed separately.
Maximal voluntary contractions (MVCs)
Functional changes in FM muscles are often assessed by
measuring strength and endurance, and the most frequent
findings are reduced exercise endurance [32], reduced vol-
untary muscle force [6,7], and a perceived greater effort
during fatigue [32]. However, other studies have found no
differences in maximal voluntary strength between FM
and healthy subjects [16,33], and their results are sup-
ported by our own MVC findings, which suggest that no
strong and unequivocal muscle fibre modifications (in
distribution, size or type) occur in FM (Table 2).
Myoelectrical manifestations of fatigue
Using both voluntary and electrically elicited contractions
makes it possible to identify the site of impairment along
the neuromuscular chain: differences in the myoelectric
manifestations of fatigue observed only during voluntary
contractions can be related to an altered motor control
strategy, whereas differences observed only during electri-
cally elicited contractions can be considered as being
mainly due to membrane properties [15].
As we found between-group differences in the EMG varia-
bles assessed on the basis of signals recorded during vol-
untary but not electrically elicited contractions, it is
possible to localise functional impairment in FM at a
higher level than that of the muscle membrane.
In line with other studies [18,40-43], although adopting a
different approach, we can conclude that the lack of myo-
electrical fatigue and the associated muscle symptoms in
FM syndrome are more likely to be generated by an alter-
ation in central nervous system motor recruitment strate-
gies than by peripheral mechanisms within the muscle
itself [43,44]. The reduced EMG manifestations of fatigue
and the type II fibre hypotrophy shown histologically in
FM [10,45-49]. have also been found in chronic fatigue
syndrome and interpreted as a sign of de-conditioning
[50].
The CV rate of change and the normalised rate of change
estimated from the extracted MUAP pool were in line with
the MNF findings. As CV estimates provide a clear physio-
logical description of the fatiguing mechanism, these
results confirm the MNF findings.
Distribution of muscle fibre conduction velocity (CV)
Differences in the distribution and skewness of CV are
usually explained as a consequence of different MU pool
recruitment, with increases in average CV being due to an
increase in faster MU recruitment [51]. The mean CV dis-
tribution and skewness values in our FM patients were
higher than those in the MCG during the 60% MVC,
which leads us to conclude that FM patients recruit more
of the faster MUs, and so an increase in the s-EMG signs of
muscle fatigue can be expected. Similar observations were
made by Gerdle et al. in their study of trapezius muscle
[52]: the CV values in the FM subjects were higher than
those in the controls during low level contractions (no
load, 1 kg, and 2 kg).
The dissociation between the curve of CV distribution and
the myoelectrical manifestations of fatigue in our FM
patients can be interpreted on the basis of an anomalous
sensory-motor system pattern and the use of non-physio-
logical strategies in managing functional motor tasks, as
seen in chronic fatigue syndrome [53].
The CV distribution curves and estimates from each
extracted MUAP offer two not necessarily matching
descriptions because fast MUAPs can be recruited fre-
quently (thus increasing the number of bins on the right
side of the distribution: see Figure 2, upper row) but only
for short periods without increasing the myoelectrical
manifestations of fatigue (see Table 2).
Altered order of recruitment in FM
The theoretical possibility of an altered order of recruit-
ment/de-recruitment has recently been experimentally
demonstrated by means of a technique based on EMG sig-
nals [54] and, given the findings described above, it can be
speculated that patients affected by FM use compensatory
motor strategies to recruit MUs in a different manner from
that expected predicted by Henneman's principle. The
wider CV distributions and fewer myoelectrical manifesta-
tions of fatigue observed in our FM group may therefore
be due to the recruitment/de-recruitment of a partially or
non-fatigued MU.Page 7 of 9
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coefficient of variation (COV) of the force generated dur-
ing isometric exercise at 60% MVC was calculated with the
assumption that the hypothesised higher level of recruit-
ment/de-recruitment in the FM group is related to a higher
COV in mechanical output. The COVs in the two groups
were not statistically different, but did show a trend in the
hypothesised direction.
An altered recruitment/de-recruitment pattern can be con-
sidered a motor response to an alteration in the central
integration of sensory inputs [51,55], and the presence of
central hyper-excitability has also been observed by others
as a neurophysiological mechanism of muscle pain in FM
[5,40,51,56] Our findings confirm the concomitant pres-
ence of central sensitisation and functional abnormalities
in muscle contraction (i.e. the recruitment and de-recruit-
ment of muscle fibres during a 60% MVC) in FM during
maximal/sub-maximal load and static contraction
observed by other authors [57].
Conclusion
The observed alteration in physiological recruitment
order seems to be the main electrophysiological character-
istic of FM central motor control failure, and can be con-
sidered a sort of kinesiophobic defensive/compensatory
strategy [58].
Our findings suggest a strong correlation between the
established presence of altered sensory afferents and inte-
gration, and the concomitant presence of alterations in
the efferent central motor command revealed by the use
of non-physiological strategies in managing functional
motor tasks. As far as we know this relationship has never
previously been reported and supported by s-EMG data.
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